Psychometric Properties of the SymptoMScreen Questionnaire in a Mild Disability Population of Patients with Relapsing–Remitting Multiple Sclerosis: Quantifying the Patient’s Perspective

Autor: José Meca-Lallana, Jorge Maurino, Miguel Ángel Hernández-Pérez, Ángel P. Sempere, Luis Brieva, Elena García-Arcelay, María Terzaghi, Gustavo Saposnik, Javier Ballesteros

Publikováno v: Neurology and Therapy, Vol 9, Iss 1, Pp 173-179 (2020)

Abstract Crucial elements for achieving optimal long-term outcomes in multiple sclerosis (MS) are patient confidence and effective physician–patient communication. Patient-reported instruments may provide the means to fill the gap in currently avai

Externí odkaz: https://doaj.org/article/37c6b7494e154f6a9e0c6c68a9a8f29d

Quantifying the patient´s perspective in neuromyelitis optica spectrum disorder: Psychometric properties of the SymptoMScreen questionnaire.

Autor: José E Meca-Lallana, Jorge Maurino, Francisco Pérez-Miralles, Lucía Forero, María Sepúlveda, Carmen Calles, María L Martínez-Ginés, Inés González-Suárez, Sabas Boyero, Lucía Romero-Pinel, Ángel P Sempere, Virginia Meca-Lallana, Luis Querol, Lucienne Costa-Frossard, Daniel Prefasi, Rocío Gómez-Ballesteros, Javier Ballesteros

Publikováno v: PLoS ONE, Vol 16, Iss 7, p e0255317 (2021)

BackgroundThe assessment of self-reported outcomes in neuromyelitis optica spectrum disorder (NMOSD) is limited by the lack of validated disease-specific measures. The SymptoMScreen (SyMS) is a patient-reported questionnaire for measuring symptom sev

Externí odkaz: https://doaj.org/article/189bfa11ecd7489bb2290d28a62384b2

Contribution of Gray Matter Atrophy and White Matter Damage to Cognitive Impairment in Mildly Disabled Relapsing-Remitting Multiple Sclerosis Patients

Autor: Ángela Bernabéu-Sanz, Sandra Morales, Valery Naranjo, Ángel P. Sempere

Publikováno v: Diagnostics, Vol 11, Iss 3, p 578 (2021)

Cognitive impairment (CI) is frequently present in multiple sclerosis patients. Despite ongoing research, the neurological substrates have not been fully elucidated. In this study we investigated the contribution of gray and white matter in the CI ob

Externí odkaz: https://doaj.org/article/aeedbe1a8ce54a07b7ab1c2509b0e8dd

Cognitive Performance and Health-Related Quality of Life in Patients with Neuromyelitis Optica Spectrum Disorder

Autor: Elisabet Lopez-Soley, Jose E. Meca-Lallana, Sara Llufriu, Yolanda Blanco, Rocío Gómez-Ballesteros, Jorge Maurino, Francisco Pérez-Miralles, Lucía Forero, Carmen Calles, María L. Martinez-Gines, Inés Gonzalez-Suarez, Sabas Boyero, Lucía Romero-Pinel, Ángel P. Sempere, Virginia Meca-Lallana, Luis Querol, Lucienne Costa-Frossard, Maria Sepulveda, Elisabeth Solana

Publikováno v: Journal of Personalized Medicine
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
Journal of Personalized Medicine; Volume 12; Issue 5; Pages: 743
Dipòsit Digital de la UB
Universidad de Barcelona

Background: The frequency of cognitive impairment (CI) reported in neuromyelitis optica spectrum disorder (NMOSD) is highly variable, and its relationship with demographic and clinical characteristics is poorly understood. We aimed to describe the co

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::def300a349587b1dcb26773d9da41ce0
http://hdl.handle.net/2445/187054

High-Efficacy Disease-Modifying Therapies in People with Relapsing-Remitting Multiple Sclerosis: The Role of Risk Attitude in Treatment Decisions

Autor: Jorge, Maurino, Javier, Sotoca, Ángel P, Sempere, Luis, Brieva, Carlos, López de Silanes, Ana B, Caminero, María, Terzaghi, Julia, Gracia-Gil, Gustavo, Saposnik

Publikováno v: The patient. 14(2)

Risk attitude is defined as the willingness to tolerate risk to achieve a greater expected return. Limited information is available on how relapsing-remitting multiple sclerosis people's perceptions about disease trajectory and risk attitude may infl

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::e9b8ba261c733f8b9d3410076e28b183
https://pubmed.ncbi.nlm.nih.gov/32975737